It has already been shown that neutralization of the activating NK cell receptor NKG2D in combination with co-stimulation blockade prolongs graft survival of vascularized transplants. In order to clarify the underlying cellular mechanisms, we transplanted complete MHC-disparate BALB/c-derived cardiac grafts into C57BL/6 wildtypes or mice deficient for NKG2D (Klrk1 with CTLA4-Ig resulted in a significant acceleration of cardiac rejection by Klrk1 −/− recipients, and this result was confirmed by applying a neutralizing antibody against NKG2D to wildtypes. In both experimental setups, grafts derived from Klrk1 −/− recipients were characterized by significantly higher levels of interferon-γ mRNA, and both CD4 + and CD8 + T cells displayed a greater capacity for degranulation and interferon-γ production. In summary, our results clearly illustrate that NKG2D expression in the recipient is important for cardiac allograft survival, thus supporting the hypothesis that impairment of NK cells prevents the establishment of graft acceptance.
It has already been shown that neutralization of the activating NK cell receptor NKG2D in combination with co-stimulation blockade prolongs graft survival of vascularized transplants. In order to clarify the underlying cellular mechanisms, we transplanted complete MHC-disparate BALB/c-derived cardiac grafts into C57BL/6 wildtypes or mice deficient for NKG2D (Klrk1 −/− ). Although median survival was 8 days for both recipient groups, we detected already at day 5 posttransplantation significantly greater intragraft frequencies of NKp46 + NK cells in Klrk1 −/− recipients than in wildtypes. This was followed by a significantly greater infiltration of CD4 + , but a lesser infiltration of CD8 + T cell frequencies. Contrary to published observations, co-stimulation blockade with CTLA4-Ig resulted in a significant acceleration of cardiac rejection by Klrk1 −/− recipients, and this result was confirmed by applying a neutralizing antibody against NKG2D to wildtypes. In both experimental setups, grafts derived from Klrk1 −/− recipients were characterized by significantly higher levels of interferon-γ mRNA, and both CD4 + and CD8 + T cells displayed a greater capacity for degranulation and interferon-γ production. In summary, our results clearly illustrate that NKG2D expression in the recipient is important for cardiac allograft survival, thus supporting the hypothesis that impairment of NK cells prevents the establishment of graft acceptance.
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| INTRODUCTION
The influence of natural killer (NK) cells in solid organ transplantation (SOT) has been comprehensively illustrated, 1 although their exact role is still a matter of controversial discussion. Infiltration of NK cells in renal and cardiac allografts before evidence of T cell infiltration has already been observed shortly after transplantation, thus supporting the role of these cells as early innate effector cells in response to inflammatory stimuli. However, whereas authors report that NK cells are important for tolerance induction either by killing graft-derived antigen-presenting cells (APCs) [2] [3] [4] or by downregulating the homeostatic proliferation of CD8 + memory T cells, 5 other publications illustrate their involvement in allograft destruction and the development of chronic allograft vasculopathy. 6 Apart from their functional role as "killers," recent reports even suggest that NK cells also possess adaptive immunity properties. 7, 8 The NK cell-mediated initiation and regulation of an alloimmune response posttransplantation might rely on the differentiation and activation status of NK cells, their expression of activating as well as and attenuates chronic allograft vasculopathy. 19 However, no information is provided regarding the influence of NKG2D neutralization at the cellular and molecular level. Therefore, we performed more profound experiments as previously reported using a NKG2D-deficient mouse in an acute transplantation setting and in a co-stimulation blockade setting of heterotopic heart transplantation. 
| ANIMALS AND METHODS

| Mice
| Experiment design
For the acute rejection model, BALB/c donor hearts were heterotopically transplanted into either C57BL/6 or Klrk1 −/− recipient mice 
| Cardiac allotransplantation
Allogeneic cervical heart transplantations were performed under injection anesthesia with ketamine/xylazine (AniMedica, Senden-Bösensell, Germany) as previously described. 21 Cold and warm ischemia times for allografts were maintained at 10 minutes. Rejection was defined as complete cessation of palpable ventricular contractions.
| Flow cytometry
Mononuclear cells (MNCs) from spleen, lymph nodes, and allografts were isolated as previously described. Figure S1 . 
T A B L E 1 Antibodies
| In vitro assays
Functional analysis of NK and T cells was performed using isolated splenic MNC cultured in RPMI 1640 medium (Lonza, Verviers, Belgium) supplemented with 10% heat-inactivated fetal calf serum, 1% l-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco/Invitrogen, Carlsbad, CA) and 400 U/mL mIL-2 (eBioscience, Table 1 .
| Quantitative reverse transcription polymerase chain reaction
Allografts were snap-frozen in liquid nitrogen and isolated splenocytes were frozen in lysis buffer at −20°C. 
| Histology and immunohistology
Tissues were fixed in 10% neutral buffered formalin and embedded in paraffin; 5-μm sections were stained with H&E and scored according to the International Society for Heart and Lung Transplantation (ISHLT) rejection score. 
| Statistical analyses
Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, La Jolla, CA). Kaplan-Meier plots were used to analyze graft survival, and a log-rank test was used to assess the statistical significance of differences between survival curves. For normally distributed data, statistical significance between 2 groups was calculated using 2-tailed Student t tests and for more than 2 groups using 1-way ANOVA.
Adjustments for multiple comparisons were performed with the TukeyKramer comparison test. Statistical significance was considered for the following P values: ns = P > .05, *P ≤ .05, **P ≤ .01, ***P ≤ .001.
| RESULTS
| Deletion of Klrk1 results in an early intragraft infiltration of NK cells
In a first set of experiments, we transplanted allogeneic BALB/c donor hearts into either naïve wildtype C57BL/6 mice or Klrk1 −/− mice. No significant differences in allograft survival were observed between the 2 groups (median survival: 8 days for each group; P = n.s.) in this acute rejection setting ( Figure 1A ). Histological analysis revealed that BALB/c grafts were characterized by a massive lymphocyte infiltration at d5 in both recipient groups ( Figure 1B ). However, already at d5, heart grafts of Klrk1 −/− recipients were characterized by a significant infiltration of NKp46 + NK cells as compared with wildtype mice, and this observation was further confirmed for spleen (P < .001) ( Figure 1C) . Contrarily, at dRx we detected a significantly enhanced infiltration of CD4 + T cells into grafts of Klrk1 −/− recipients, whereas significantly lower frequencies of CD8 + T cells were observed (P < .001). In addition, spleens and lymph nodes of Klrk1 −/− mice showed enhanced frequencies of major histocompatibility complex (MHC) class II
+
CD11c
+ dendritic cells as early as d5 (P < .01) as well as dRx (P < .001 for spleen, Figure 1C ).
Interestingly, Klrk1 −/− mice had significantly fewer numbers of regulatory T (T REG ) cells in lymph nodes at d5 (P < .05) ( Figure S2 ).
| Klrk1
−/− -derived T cells illustrate greater degranulation capacity and IFNγ production Whereas no differences for RAE1, MULT-1, and H60 mRNA in allografts between Klrk1-/-recipients and wildtype mice were observed (data not shown), ligand expression of RAE1 g was induced between d5 and dRx on both splenic conventional dendritic cells (cDC) and plasmacytoid cells (pDCs). Especially cDCs derived from Klrk1-/-lymph nodes displayed significantly weaker ligand expression than 
| Klrk1 deficiency of the recipient results in accelerated rejection of allogeneic grafts under costimulation blockade
It has been demonstrated that the neutralization of NKG2D in combination with co-stimulation blockade results in prolonged cardiac graft survival. 17, 19 We therefore transplanted BALB/c-derived hearts into either C57BL/6 or Klrk1 -/-mice receiving a single dose of abatacept at d2 posttransplantation. 22 Surprisingly, whereas co-stimulation blockade resulted in a median survival of 50 days in wildtype animals, Klrk1
-/-mice treated with abatacept displayed significantly reduced graft survival (median survival: 27 days; P = .0015). We repeated these experiments applying a neutralizing antibody against NKG2D. Again, we were able to illustrate that NKG2D-neutralized wildtype mice under co-stimulation blockade displayed significantly reduced graft survival as compared with mice treated with an isotype control (median survival: 22.5 days versus 47.5 days; P = .0074), which is comparable with the graft survival of Klrk1 -/-mice ( Figure 3A ). At d20, the time when hearts engrafted into Klrk1 -/-mice start to be rejected, allografts were characterized by a higher although not significant ISHLT rejection score ( Figure 3B ). Thus, our survival data clearly illustrate that under co-stimulation blockade NKG2D expression of the recipient is important for allograft survival.
| NK cell infiltration in cardiac grafts is impaired under co-stimulation blockade
Contrary to the acute rejection setting ( Figure 1C) , frequencies of graft-infiltrating NKp46 + NK cells at d5 were significantly reduced in Klrk1 -/-mice under co-stimulation blockade, whereas splenic CD4 + T cells were decreased and CD8 + T cells increased. At d20 no differences between wildtype in Klrk1 -/-mice were observed anymore with the exception of elevated NK cell frequencies in lymph nodes (Figure 4 ). In addition, these mice further demonstrated significantly elevated frequencies of splenic Treg ( Figure S4 ).
| Maintained degranulation capacity and IFNγ production of Klrk1 -/-T cells under co-stimulation blockade
We monitored RAE1 g expression on APCs and detected a significantly induced expression on cDCs and pDCs derived from Klrk1 -/-spleens and lymph nodes already at d5. Induction on splenic cDCs was also observed at d20 ( Figure 5A ). As in the acute model, both CD4 + and CD8 + T cells derived from Klrk1 -/-mice still displayed enhanced degranulation capacity at d5 as compared with wildtype animals. Contrarily, no differences were observed for NK cells under co-stimulation blockade at d5 ( Figure 5B ). However, all investigated cell subtypes derived from knockout animals showed significantly elevated IFNγ expression at d5, which is inversed at d20. Cardiac allografts derived from Klrk1 -/-mice displayed significantly elevated mRNA levels of IFNγ, Granzyme B, and tumor necrosis factor-α ( Figure 5C ), and splenic gene expression analysis revealed an induction of IFNγ, IL-2, and CXCL10 ( Figure S5 ). arise: first, why do these data contrast sharply with already published data, and, second, why is the deletion of NKG2D, an activating NK cell receptor, important for allograft survival although its functional importance for reactivity has been considerably illustrated in tumor models. For instance, mice deficient for NKG2D or treated with
| DISCUSSION
-/-mice. Hearts were acutely rejected at 8 days (median) in both groups, n = 6/group. (B) Exemplary pictures of graft histology illustrating that grafts harvested from either C57BL/6 or Klrk1 -/-recipients were characterized by massive lymphocyte cell infiltration at dRx. Scale bar = 100 μm. (C) Analysis of lymphocyte subsets derived from allografts, spleen, and lymph nodes at d5 and dRx. Data are presented as mean values for 5-6 animals/group. Statistically significant differences were tested with 1-ANOVA; *P < .05, **P < .01, ***P < .001. d5, day 5; DCs, dendritic cells; dRx, day of rejection
an NKG2D-neutralizing antibody are more susceptible to primary tumorigenesis.
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Direct comparison of our results with previous reports appears difficult, as we transplanted donor hearts cervically 21, 22 and not hetero- neutralization at day 60. 19 However, we did not detect differences in the same experimental set-up already at day 20 posttransplantation (Figure 4) . Moreover, the same authors conclude that expansion of T REG is one of the main mechanisms contributing to prolonged graft ISHLT, International Society for Heart and Lung Transplantation; **P < .01; n.s., not significant F I G U R E 4 Lymphocyte composition in recipient graft, spleen, and lymph nodes under co-stimulation blockade. Analysis of lymphocyte subsets derived from allografts, spleen, and lymph nodes at day 5 (d5) and d20. Data are presented as mean values for 5-6 animals/group. Statistically significant differences were tested with 1-way ANOVA; *P < .05, **P < .001; ***P > .0001. DCs, dendritic cells; MHC, major histocompatibility complex; NK, natural killer pleted, transplant tolerance of MHC-mismatched allografts would be difficult to achieve. [2] [3] [4] [5] [6] This result overturns the general belief that NK cells should be regarded solely as "killers" and shows that they appear to have an important regulatory role.
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